Company Profile
Catheter Precision Stock Price, News & Analysis
- Ticker:
- VTAK
- Exchange:
- NYSE
- Sector:
- MedTech
- Location:
- United States
Stock performance
0.27 USD (-1.92%)
Close
Last updated: August 6, 2026
2.58M USD
Market cap
Why the stock is moving
The latest monitored company update is “Flyte Achieves Record Revenues in July.” The corresponding closing-price reaction is not yet available.
Company overview
Business overview
Catheter Precision is a medical technology company focused on electrophysiology and catheter-based tools used in cardiac procedures. Its business is centered on procedural guidance rather than drug development.
Geographic Base and Sector Classification
Catheter Precision is headquartered in the United States and listed on NASDAQ. It sits in cardiac-device medtech rather than biotechnology.
Business Model Characteristics
The company depends on device adoption, physician training, and regulatory or commercial milestones in electrophysiology labs. Investors watch product uptake, procedure placement, and operating execution.
Position Within the Biotechnology Landscape
Catheter Precision occupies a cardiac-device niche within healthcare innovation. It is not biotech, but it belongs in the procedural-medtech layer where clinical adoption drives value.
Future catalysts
Catheter Precision’s catalysts are EP-device adoption, procedural workflow growth, and any strategic update that clarifies the company’s commercialization path. The market will care about whether the platform can keep winning procedure share.
Recent news
- 01
Flyte Achieves Record Revenues in July
Source: Catheter Precision
- 02
- 03
Flyte Partners with LDV at The Maidstone to Elevate Luxury Travel to the Hamptons
Source: Catheter Precision
- 04
FLYTE Partners with 319 Golf Society and Named Exclusive Private Aviation Partner
Source: Catheter Precision
- 05
Flyte Partners with Blade to Expand Vision Jet Distribution
Source: Catheter Precision
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Catheter Precision (VTAK)?
Catheter Precision (VTAK) most recently closed at 0.27 USD, a -1.92% move versus the previous session.
What is the market cap of Catheter Precision (VTAK)?
Catheter Precision currently has a market capitalization of 2.58M USD on BioPharmSignal.
What does Catheter Precision do?
Catheter Precision is a medical technology company focused on electrophysiology and catheter-based tools used in cardiac procedures. Its business is centered on procedural guidance rather than drug development.
On which exchange is VTAK stock listed?
Catheter Precision (VTAK) is associated with NYSE, United States, MedTech.
What is Catheter?
Catheter Precision’s catalysts are EP-device adoption, procedural workflow growth, and any strategic update that clarifies the company’s commercialization path.
Which conditions is Catheter Precision targeting with Catheter?
Catheter Precision’s catalysts are EP-device adoption, procedural workflow growth, and any strategic update that clarifies the company’s commercialization path.
How does Catheter Precision describe recent progress with Catheter?
Catheter Precision’s catalysts are EP-device adoption, procedural workflow growth, and any strategic update that clarifies the company’s commercialization path.
What is Precision?
Catheter Precision is a medical technology company focused on electrophysiology and catheter-based tools used in cardiac procedures.